| Voice alarm system | with the voice alarm system to  make the syringe process safe and reliable |
| Flow rate |
50ml syringe:0.1-1500ml/h 30ml syringe :0.1-900.0ml/h 20ml syringe:0.1-600.0ml/h 10ml syringe:0.1-300.0ml/h |
| Range of injected volume | 0-9999.9ml |
| Accuracy of flow rate | ±2% with correct calibration |
Describe
1. Three Vein Infusion Models:
A. Time-Volume Mode: By setting the time and injection volume, the system does the injection after automatic speed calculation.
B. Dosage Weight Mode: By setting the volume, weight, medicament, dosage, the system does the injection after automatic speed calculation.
C. Easy Speed-Setting Mode: The normal one hospitals used.
2. Function to remove bubbles in the tube fast.
3. Function to handle fast speed and large volume(bolus)
4. The system automatically opens up KVO after injection(reopens vein circulation)
5. Function to Preset Solution Volume: The user can preset solution volume. The machine will automatically stop and start KVO function once the preset solution volume is finished.
6. The machine automatically records the settings for last injection. It greatly reduces the workload for users.
7. Function to Auto-Define a Syringe: Complete calibration technology for syringe brand definition that ensures the compatibility of any syringe brand and injection accuracy.
8. Voice Prompt and Voice Alarm Function: Voice prompt and alarm will sound when injection is almost done, injection is finished, preset dosage is done, an injection blockage occurs, syringe device is improperly installed, a wrong speed is set, AC is unplugged, battery is close to zero. This further greatly reduces the workload of nurses(only available from our company)
Features:
1. Freely Stackable: You freely stack one onto another to provide multiple solutions, combination solutions that have a wide range of clinical applications.
2. Three Power Source: AC220\50Hz, Internal Battery, 12V car charge
3. Digital LCD display: High capacity words, friendly user interface, dynamically display working status.
4. Positive and Negative Shuttle Debugger: Can freely regulate parameters.
5. Mechanism Advantage of Push-Pull Rod:
A. Applicable to all domestic brands and all kinds of syringes.
B. Operable with one hand in a No-Germ environment
Â
LCZ696 (Valsartan/sacubitril) is a combination drug for use in heart failure developed by Novartis. It consists of the angiotensin receptor blocker valsartan and the neprilysin inhibitor sacubitril, in a 1:1 mixture by molecule count. It may be used instead of an ACE inhibitor or an angiotensin receptor blocker in people with heart failure with reduced ejection fraction. The combination is sometimes described as an "angiotensin receptor-neprilysin inhibitor" (ARNi).
It was approved under the FDA's priority review process on July 7, 2015. It is also approved in Europe.
We produce a series of complete intermediates for LCZ696, intermediate I (CAS No. 1426129-50-1) and intermediate II (CAS No. 1012341-50-2) etc.
All of our products are with stable production and strict quality control, making sure your experience with Sunshine Biotech is always enriching, satisfying and fulfilling.
Lcz696 Intermediates,Cas 1426129-50-1,Cas 1012341-50-2,High Purity Lcz696 Intermediate
Nanjing Sunshine Biotech Co., Ltd , http://www.sunshine-bio.com